Skip to main content

Our Expertise

Having over 40 years of collective experience in all phases of drug and biologics development, Geis-Hides Consulting has submitted 14 regulatory market applications with 9 approvals, including 5 new drugs.

We attribute this success to our strategy that focuses on the anticipated final product label early in the drug development process. The approach maximizes efficiencies in clinical development and conserves financial resources.

We define this approach as Target-Driven Development.

Geis-Hides Consulting assimilates the clinical and medical goals with the corporate and capital needs of the organization. In a complex environment of translational drug research, we innovate durable solutions that build a solid medical and scientific foundation for growth.

Premium Drupal Themes by Adaptivethemes